Gabapentin Uses Beyond Neuropathic Pain
Gabapentin is FDA-approved for two primary indications: postherpetic neuralgia and adjunctive therapy for partial-onset seizures in adults and children ≥3 years old. 1
FDA-Approved Indications
Beyond neuropathic pain management, gabapentin's only other FDA-approved indication is:
Epilepsy/Seizure Management
- Adjunctive therapy for partial-onset seizures (with or without secondary generalization)
- Approved for adults and pediatric patients ≥3 years old
- Used when added to existing antiepileptic drug regimens
- Demonstrated efficacy in reducing seizure frequency by ≥50% in refractory cases 1
Off-Label Uses Supported by Evidence
While not FDA-approved, gabapentin has evidence supporting several off-label applications:
1. Perioperative Pain Management
Multiple well-designed trials demonstrate gabapentin reduces postoperative pain and opioid requirements in:
- Otolaryngology procedures
- Orthopedic surgery
- Mastectomy
- Abdominal/pelvic surgery
However, gabapentin shows limited or no efficacy for cardiothoracic surgery 2
2. Cancer-Related Pain
- Effective for neuropathic cancer pain when combined with opioids
- Reduces total opioid dose requirements
- Particularly beneficial in head/neck malignancies during radiotherapy or chemoradiotherapy
- The combination of gabapentin plus morphine provides superior pain relief at lower doses of each drug compared to either alone 3
3. Fibromyalgia and Chronic Widespread Pain
Evidence-based guidelines support gabapentinoid trials (particularly pregabalin, but gabapentin by extension) for severe fibromyalgia pain that interferes with quality of life 4
Important Clinical Caveats
What Gabapentin Does NOT Work For:
- Acute postoperative pain at rest - showed no benefit versus placebo 5
- Peripheral nerve injuries - recent high-quality meta-analysis found no clinically meaningful reduction in pain or sleep disruption 6
- Non-neuropathic pain generally - lacks efficacy and carries increased adverse reaction risk 7
Critical Safety Considerations:
Never stop gabapentin abruptly - particularly in epilepsy patients, as sudden discontinuation can precipitate status epilepticus (seizures that won't stop) 1
Black box warnings include:
- Suicidal thoughts/behavior (1 in 500 patients)
- Behavioral changes in children 3-12 years (aggression, hyperactivity, concentration problems)
- Serious allergic reactions affecting skin, liver, or blood cells 1
Common problematic side effects in older adults:
- Somnolence, dizziness, mental clouding
- Weight gain and peripheral edema
- Start at very low doses (100-200 mg/day) and titrate slowly 4
Dosing Adjustments Required:
- Reduce dose with creatinine clearance <60 mL/min
- Gabapentin is eliminated unchanged in urine 4
Bottom Line
Gabapentin's only FDA-approved use beyond neuropathic pain is as adjunctive therapy for partial-onset seizures. Off-label perioperative and cancer pain applications have supporting evidence, but recent high-quality data refute its effectiveness for non-neuropathic pain conditions. Given substantial side effects and increasing misuse potential, restrict gabapentin use to FDA-approved indications unless compelling evidence supports specific off-label applications in individual clinical scenarios.